HUBEI ENORAY BIOPHARMACEUTICAL CO LTD

Overview

HUBEI ENORAY BIOPHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering ENOXAPARIN SODIUM USP; HEPARIN SODIUM CRUDE; HEPARIN SODIUM USP.

API / Drug Master Files

HUBEI ENORAY BIOPHARMACEUTICAL CO LTD holds 3 active (3 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ENOXAPARIN SODIUM USPActive2017-12-13
• HEPARIN SODIUM CRUDEActive2017-01-04
• HEPARIN SODIUM USPActive2016-02-12

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to HUBEI ENORAY BIOPHARMACEUTICAL CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.